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ABSTRACT Dihydroorotate dehydrogenase (DHODH) catalyzes the oxidation of dihydroorotate to orotate during the fourth
step of the de novo pyrimidine synthesis pathway. In rapidly proliferating mammalian cells, pyrimidine salvage pathway is
insufﬁcient to overcome deﬁciencies in that pathway for nucleotide synthesis. Moreover, as certain parasites lack salvage
enzymes, relying solely on the de novo pathway, DHODH inhibition has turned out as an efﬁcient way to block pyrimidine
biosynthesis. Escherichia coli DHODH (EcDHODH) is a class 2 DHODH, found associated to cytosolic membranes through
an N-terminal extension. We used electronic spin resonance (ESR) to study the interaction of EcDHODH with vesicles of
1,2-dioleoyl-sn-glycero-phosphatidylcholine/detergent. Changes in vesicle dynamic structure induced by the enzyme were
monitored via spin labels located at different positions of phospholipid derivatives. Two-component ESR spectra are obtained
for labels 5- and 10-phosphatidylcholine in presence of EcDHODH, whereas other probes show a single-component spectrum.
The appearance of an additional spectral component with features related to fast-motion regime of the probe is attributed to the
formation of a defect-like structure in the membrane hydrophobic region. This is probably the mechanism used by the protein to
capture quinones used as electron acceptors during catalysis. The use of speciﬁc spectral simulation routines allows us to
characterize the ESR spectra in terms of changes in polarity and mobility around the spin-labeled phospholipids. We believe
this is the ﬁrst report of direct evidences concerning the binding of class 2 DHODH to membrane systems.
INTRODUCTION
Growing organisms need nucleotides, the building blocks of
DNA, RNA, and other biologically essential molecules. In-
hibitors of nucleotide synthesis form an important group of
chemotherapeutic agents, and cells that rely on this pathway
are especially susceptible to such inhibitors. The de novo
pyrimidine pathway seems to be significantly important.
Besides RNA and DNA synthesis, pyrimidines are also
needed for protein glycosylation, membrane lipid biosyn-
thesis, and strand break repair (1–23). Several inhibitors of
the enzyme involved in the only redox step of pyrimidines
nucleotide pathway, dihydroorotate dehydrogenase (DHODH),
have been in clinical trials and one inhibitor, Arava (le-
flunomide; Sigma, St. Louis, MO), has been approved for
human use as rheumatoid arthritis agent (4,5). In addition, the
increased interest in DHODH is due to its role as a target for a
number of biologically active chemical or natural compounds.
The enzyme has been identified as a pharmacological target
for isoxazole, triazine, cinchoninic acid and (naphtha)quinone
derivatives, which exerted antiproliferative, immunosup-
pressive, and antiparasitic effects (6–8). These compounds
were found to interfere with aberrant imunological reactions,
to combat parasitic protozoa infections, like malaria, to pre-
vent the spreading of animal parasitic diseases, and to support
antiviral therapies, by lowering the intracellular concentra-
tions of pyrimidine nucleotides (9).
Dihydroorotate dehydrogenase catalyses the fourth se-
quential step in the de novo pyrimidine nucleotide synthesis
pathway with the oxidation of dihydroorotate to orotate, the
first aromatic intermediate in this biosynthetic pathway, with
the aid of a flavin cofactor and an electron receptor (1). On the
basis of sequence similarity, the DHODHs can be divided in
two major classes (2). This division correlates with subcel-
lular location of the proteins as well as their preferences
for electron acceptors. Enzymes of class 1, found in Gram-
positive bacteria and in the anaerobic yeast Saccharomyces
cerevisiae, are located in the cytosol of the cell. They share
,20% sequence identity with the membrane-bound enzymes
of class 2, found in eukaryotes and in some prokaryotes such
as the Gram-negative bacteria related to Escherichia coli.
Class 1 enzymes can be further divided into two subtypes,
namely 1A and 1B. The eukaryotic class 2 enzymes are located
in the inner membrane of mitochondria and, in the case of
E. coli enzyme, are associatedwith the cytoplasmaticmembrane.
The structure of DHODH has been solved for four dif-
ferent organisms: Homo sapiens (HsDHODH) (10), E. coli
(EcDHODH) (11), rat (12), Plasmodium falciparum (13),
and Lactococcus lactis (3,14,15). The latter includes sub-
types A and B of class 1 DHODHs. In all cases the structure
of DHODH is an a/b barrel with eight parallel b strands
forming the barrel and a helices wrapped around the outside.
The orotate active site is at the top of the barrel where several
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additional strands form a binding pocket for the flavin co-
factor and orotate. In addition to this main barrel, class 2
DHODH, such as HsDHODH and EcDHODH, contains a
second domain situated at the N-terminus, which is supposed
to be involved with membrane interaction (11).
Another remarkable difference between the two classes of
DHODH is related to the mechanism used by them to com-
plete the redox reaction. In class 1 DHODHs, the electron
acceptors involved in the second half reaction of the redox
process are either fumarate or NAD1 (1) whereas for class 2
DHOHDs this role is played by quinones present in the bi-
ological membranes (16,17). In the latter case, the N terminus
has been proposed as the binding site for the electron acceptor
(10). Thus, this N-terminal domain is supposedly responsible
for both membrane association and binding of electron ac-
ceptor molecules.
Electron spin resonance (ESR) is a powerful technique that
makes use of either transition metal ions or spin probes,
usually involving stable nitroxide radicals bound to mole-
cules such as phospholipids or cysteine residues in proteins,
to monitor changes in the probe vicinity (18–21). Some ad-
vantages of spin-labeling ESR experiments are the possibility
of using a selective probe that has a simple ESR spectra and
their high sensitivity to the molecular motion of the spin-
bearing moiety. The changes in the nitroxide surroundings
can be related to a variety of biologically-relevant processes
such as protein conformational changes (22–24), lipid-protein
interactions (25–28), and the dynamic structure of biologic
and model membranes (29–32).
In this article, we use ESR to monitor EcDHODH-induced
changes in the neighborhood of spin-labeled phospholipids
incorporated into a membrane model system. We address the
main goal of investigating the effect of EcDHODH binding to
phospholipid vesicles. The use of specific spectral simulation
routines allows us to fully characterize the ESR spectra in
terms of changes in polarity and mobility in the surroundings
of the spin-labeled phospholipid molecules. To the best of
our knowledge, this is the first report showing direct evi-
dences concerning the binding of class 2 DHODH to mem-
brane systems and its implication in protein function.
MATERIALS AND METHODS
Expression and puriﬁcation of EcDHODH
PAG1 plasmid and E. coli cell strains used for EcDHODH expression were
kindly provided by Prof. K. F. Jensen (University of Copenhagen) (33).
E. coli DHODH was overexpressed in S06645 E. coli cell strain grown in
Luria-Broth medium. A cell pellet from 250 mL of cell culture was lysed in
10 mL of 50 mM sodium phosphate buffer pH 8.0 and 0.25 mM EDTA. To
the lysate was added 5mMmagnesium chloride plus 0.2%Triton X-100with
subsequent centrifugation at 17,2003 g for 1 h. The supernatant was applied
to a 20 mL DEAE-Sepharose column (Amersham Biosciences, Uppsala,
Sweden) equilibrated with 50 mM sodium phosphate buffer pH 8.0 and
0.25 mM EDTA. The column was washed with 50 mL sodium phosphate
buffer pH 8.0, 0.1 mMEDTA and 0.1%Triton X-100 and eluted with a linear
gradient from 0 to 1 M NaCl. The fractions containing EcDHODH were
combined in presence of 0.5% Triton X-100, followed by 1 M ammonium
sulfate precipitation. The mixture was incubated for 1 h at 4C and centri-
fuged at 20,0003 g for 1 h. The supernatant was applied to a 2 mL Phenyl-
Sepharose column (Amersham Biosciences) equilibrated with 50 mM sodium
phosphate buffer pH 7.0, 0.1 mM EDTA and 1.1 M ammonium sulfate. The
column was washed with a linear gradient from 1.1 to 0 M ammonium
sulfate. The protein is eluted with 50 mM sodium phosphate buffer pH 7.0,
0.1 mM EDTA and 0.5% Triton X-100.
EcDHODH/vesicles mixtures
EcDHODH is purified in the presence of the detergent Triton X-100, which is
crucial for enzyme solubilization. The absence of the detergent leads to
protein precipitation probably due to aggregation via its N-terminal domain.
The solution containing EcDHODH in the presence of Triton X-100 is added
to a dried phospholipid film formed on the wall of a glass tube from chlo-
roform stock solutions of the lipid. It is well-known that the mixture of
surfactants to phospholipids leads to alterations in the membrane structure,
which depend basically on the ratio surfactant/phospholipids (34,35). A
continuous increase in such a ratio is accompanied by a transition from a
bilayer to a monolayer structure. In our case, the detergent Triton X-100
comes from the purification/solubilization process and its final concentration
is hard to determine exactly. Several assays with different detergent con-
centration were carried out to assure that the amount of detergent present in
the final samples was the minimum required for protein solubilization. In this
work, final Triton X-100 concentration is above its critical micelle concen-
tration and we estimated the surfactant/phospholipid ratio to be close to 1,
which resulted in a mixture of mixed micelles and mixed vesicles described
by Lo´pez et al. (34) for a system constituted by Triton X-100 and phos-
phatidylcholine. To have a control experiment, enzyme-free samples con-
taining mixtures of Triton X-100 and phospholipids at similar surfactant/
phospholipid ratio as before were prepared and submitted to ESR analysis.
ESR spectroscopy
The headgroup spin label dipalmitoylphosphatidyl tempo (2,2,6,6,-tetramethyl-
1-oxy) choline (DPPTC), the phospholipid labels 1-palmitoyl-2-(n-doxyl
stearoyl) phosphatidylcholine (n ¼ 5, 10, 12, 16-PC) and the lipid
1,2-dioleoyl-sn-glycero-phosphatidylcholine (DOPC) were purchased from
Avanti Polar Lipids (Alabaster, AL). All labels and chemicals were used
without further purification. Measured stock solutions of the lipid DOPC and
the spin labels were mixed in a glass tube. The chloroform present in the
stock solutions was removed by N2 flow followed by 1 h in a Speedvac
system to ensure complete removal of the solvent. A measured amount of
the buffered EcDHODH/Triton X-100 solution was added to the sample
tube, and incubated for several minutes. A final volume of 100 mL of the
samples containing mixtures of EcDHODH/Triton X-100/DOPC/spin label
was drawn into a quartz flat cell, which was in turn placed in the ESR res-
onant cavity. Final enzyme concentration ranged from 89–103 mM. X-band
ESR spectra of those samples were recorded on a Varian E109 spectrometer
at room temperature. Acquisition conditions were: modulation amplitude,
1.0 G; modulation frequency, 100 kHz; microwave power, 10 mW; field
range, 100 G.
RESULTS AND DISCUSSIONS
ESR spectra and nonlinear least-squares analysis
The ESR spectra of the headgroup spin probe (DPPTC) as
well as acyl chain labels (5-, 10-, 12- and 16-PC) incorpo-
rated into DOPC/Triton X-100mixed vesicles in the presence
and absence of EcDHODH are shown in Fig. 1. Only minor
changes between samples with and without EcDHODH are
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detectable for DPPTC, 12-, and 16-PC probes, whereas the
appearance of a second component (sharp peak in the low-
field resonance) is observed for probes 5- and 10-PC in the
presence of the titled enzyme. In these two-component
spectra, the major contribution is attributed to the bulk la-
beled phospholipids whereas the second one is assigned to
label molecules in close contact with the protein (the so-
called boundary lipid (36–38)). A qualitative analysis of the
extra component suggests that a spectrum constituted by
sharp lines like those observed in Fig. 1 B andC should be the
result of a much less hindered motion of the spin probes when
in the vicinity of the enzyme. The faster motion experienced
by the boundary labels averages out the anisotropy of the
magnetic interactions (hyperfine and Zeeman) leading to
narrower resonance lines than usually observed for spin probes
experiencing slow and anisotropic motion. A control experi-
ment using class 1 Trypanosoma cruziDHODH (TcDHODH),
which misses the N-terminal domain (cloning, expression,
and purification of TcDHODH followed a protocol adapted
from 39), in the presence of the same membrane model
system described above yielded no alterations whatsoever in
the ESR spectra of either the headgroup or a carbon-chain
spin probe (data not shown).
To fully characterize the modifications measured in the
presence of EcDHODH, the ESR spectra of the spin probes in
mixtures of vesicle/enzyme were simulated by means of a
nonlinear least-squares program developed by Freed et al.
(40–42). The parameters involved in the fitting procedure
were as follows: hyperfine tensor components (Axx,Ayy,Azz),
rotational diffusion rates (R? and R//), and a lorentzian (1=T2)
inhomogeneous broadening. The dynamics of the spin probe
is characterized by R? and R//, which represent the rotational
diffusion rates of the nitroxide radical around the axes per-
pendicular and parallel to the mean symmetry axis for the
rotation. This symmetry axis is also the direction of prefer-
ential orientation of the spin label moiety (41). For n-PC
chain labels, R? accounts for the wagging motion of the long
axis of the carbon chain (Fig. 2 A). As for the label DPPTC, it
represents the wagging motion of the headgroup region (Fig.
2 B). To avoid local minima the simulation process was re-
started from different sets of seed values.
The ESR spectra of the spin probes incorporated into
the model membrane system (Fig. 3) can be divided, for
FIGURE 1 ESR spectra of spin labels (a) DPPTC, (b) 5-, (c) 10-, (d) 12-,
and (e) 16-PC incorporated into vesicles of DOPC/Triton X-100 in the
absence (solid line) and in the presence of EcDHODH (dashed line).
Experimental conditions: microwave frequency 9.5 GHz; modulation am-
plitude 1.0 G; modulation frequency 100 kHz; microwave power 10 mW.
FIGURE 2 Chemical structures of the (a) acyl-chain (16-PC) and (b)
headgroup (DPPTC) spin labels showing the principal magnetic axes
(xm, ym, zm).
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simulation purposes, in two categories. One comprises the
one-component spectra of DPPTC, 5-, 10-, 12-, and 16-PC in
pure vesicles (without EcDHODH) and of DPPTC, 12-, and
16-PC in EcDHODH-containing samples, which were then
treated first. Seed values for the magnetic parameters (Axx,
Ayy, Azz, gxx, gyy, gzz) were obtained from Ge et al (1990)
(43). During the simulations process, the magnetic parame-
ters were initially kept fixed, and the rotational diffusion
tensor component R? was varied. After that, variations in the
hyperfine and g-tensor components were carried out sepa-
rately to avoid high correlation values between those pa-
rameters that can come up when they are varied together.
Once a reasonable fit was obtained for the mixtures con-
taining only vesicles of DOPC/Triton X-100, the calculated
parameters thus obtained were used as starting values for the
fits of EcDHODH-containing samples. The best-fit values
calculated for the one-component ESR spectra are presented
in Table 1 and the best spectral fits are shown in Figs. 3, 4 A,
and 5 A along with the respective experimental data.
As for 5-PC two-component spectral simulation, we used
separate sets of parameters for each component. For the bulk
component, the parameters determined previously for the
one-component spectra (Table 1) were used to calculate the
spectrum of what we denoted as component 1 in Table 1.
These values were kept fixed and only the parameters for the
boundary probes (component 2 in Table 1) were allowed to
vary. The best-fit parameters thus obtained are shown in
Table 1 and the calculated spectra in Fig. 4 B, where it is also
shown the individual components calculated by the NLSL
program. As pointed out above, component 2 gives rise to
parameters attributable to a probe molecule experiencing a
fast-motion regime.
FIGURE 3 Experimental (dashed line) and simulated
(solid line) ESR spectra from (a) DPPTC, (b) 12-, and
(c) 16-PC labels in mixtures of DOPC/Triton X-100 (left
column) and DOPC/Triton X-100/EcDHODH (right col-
umn).
TABLE 1 Best-ﬁt parameters from NLSL simulations of the ESR spectra obtained from spin labels (headgroup DPPTC and n-PC)
incorporated into mixtures of DOPC/Triton X-100 and DOPC/Triton X-100/EcDHODH
Sample Component gxx gyy gzz Axx Ayy Azz A0 R? (310
8 s1)
No EcDHODH
DPPTC 1 2.0078 2.0046 2.0022 6.0 5.9 37.5 16.5 0.58
5-PC 1 2.0075 2.0049 2.0020 7.4 6.5 30.2 14.7 0.22
10-PC 1 2.0084 2.0063 2.0033 6.5 6.0 31.4 14.6 0.36
12-PC 1 2.0089 2.0063 2.0033 5.3 4.9 33.2 14.5 0.79
16-PC 1 2.0102 2.0063 2.0033 5.3 4.9 33.2 14.5 1.94
EcDHODH
DPPTC 1 2.0078 2.0047 2.0022 6.0 4.9 37.8 16.2 0.78
5-PC 1 2.0075 2.0049 2.0020 7.4 6.5 30.2 14.7 0.22
2 2.0068 2.0047 2.0015 6.5 5.2 36.3 16.0 1.47
12-PC 1 2.0090 2.0063 2.0033 5.3 4.9 33.3 14.5 0.66
16-PC 1 2.0102 2.0063 2.0033 5.3 4.9 33.3 14.5 1.69
A-tensor components are in Gauss. A0¼(Axx1Ayy1Azz)/3. Estimated errors: R? (5%), Axx and Ayy (10%), Azz (5%).
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The spectrum of the spin probe 10-PC in mixtures con-
taining the enzyme was treated differently than the 5-PC
spectrum described above. The NLSL program could not
satisfactorily handle such a weak contribution to the overall
spectrum because, in this case, the extra component is seen as
a minor bump in the low-field resonance (Fig. 5 B). Even
using two sets of parameters for the simulations, one of
them was repeatedly set as a null contribution to the overall
spectrum. A careful analysis of the individual spectrum de-
termined for component 2 of the 5-PC probe in EcDHODH-
containing model membranes (Fig. 4 B) suggested that the
general features of the sharp-line spectrum in the 10-PC case
were not dramatically different from those observed for
component 2 of the 5-PC probe. To verify whether this was a
reasonable assumption, we manually added the experimental
spectrum of 10-PC in pure vesicles (Fig. 5 A) with the cal-
culated spectrum for 5-PC boundary probe (component 2 in
Table 1 and sharp-line spectrum in Fig. 4 B). The intensities
of these individual spectra were adjusted to achieve the best
reproduction of the two-component experimental spectrum
of 10-PC in EcDHODH/DOPC/Triton X-100. A very good
agreement between the final sum spectrum and the experi-
mental 10-PC spectrum from EcDHODH-containing vesicles
was obtained as can be seen in Fig. 5 B. This indicates that 5-
and 10-PC probe molecules in contact with EcDHODH ex-
perience similar microenvironments.
Binding mechanism and enzyme catalysis
The isotropic hyperfine parameter A0 (A0¼ Axx1 Ayy1 Azz)
is a well-known measure of the relative polarity around the
nitroxide moiety (18,30,44). The higher the A0 value, the
more polar is that environment. Hence, from Table 1, we can
see that the headgroup spin label DPPTC is, as expected, in a
much more hydrophilic environment than the chain labels
showing A0 value (16.5 G) comparable to the values observed
for spin labels free in aqueous solution (ca. 16.9 G). From the
headgroup region toward the vesicle interior, the A0 values
drop down to 14.5 G for the 16-PC probe (Table 1). In the
hydrophobic part of the model membrane, A0 parameter does
not change significantly, thus suggesting that the polarity
inside the vesicle does not show abrupt alterations. The same
pattern for A0 is also obtained for the bulk labels in sam-
ples containing the enzyme (component 1 in Table 1), which
FIGURE 4 Experimental (dashed line) and calculated (solid line) ESR
spectra from 5-PC spin probe in mixtures of (a) DOPC/Triton X-100 and (b)
DOPC/Triton X-100/EcDHODH. b shows the individual components:
1 (bulk lipid, dotted line) and 2 (boundary lipid, dash-dotted line) obtained
by means of NLSL simulations.
FIGURE 5 Experimental (dashed line) and calculated (solid line) ESR
spectra from 10-PC spin probe in mixtures of (a) DOPC/Triton X-100 and
(b) DOPC/Triton X-100/EcDHODH. b shows the individual components:
1 (bulk lipid, dotted line) and 2 (boundary lipid, dash-dotted line) obtained
as described in the text.
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indicates that EcDHODH does not modify the solvent (or
other polar molecules) accessibility to the hydrophobic car-
bon chains of the vesicles.
On the other hand, a considerable increase in polarity
(from 14.7 G to 16.0 G) is observed for the component 2
in the 5- and 10-PC spectra (Table 1) in the presence of
EcDHODH. This result can be rationalized in terms of the
residue composition of the EcDHODH N-terminal domain.
The hydrophobic pattern for the residues in the two a-helices
and one 310 helix that constitute the N-terminal domain de-
termined by ProtScale software (45) (Fig. 6) allows us to infer
that such a region shows an amphipathic character with alter-
nating hydrophobic and hydrophilic regions. The existence
of a significant number of polar residues could account for the
increase in polarity observed for the component 2 of 5-PC
label in the presence of the enzyme. Norager et al. (11)
suggested that this residue distribution in the N-terminal
domain would make it possible for the enzyme to adhere to
the membrane, but not as an integral membrane protein. Our
ESR data supports this peripheral docking of EcDHODH to
membranes because major changes are observed no further
down the acyl chain than position n ¼ 10. However, we
should bear in mind that, because of the low-ordered struc-
ture of the model membrane core, the protein penetration
depth cannot be rigorously determined by our experiments.
Nevertheless we can conclude that the modifications induced
by the presence of the enzyme do take place in a somehow
localized manner. Furthermore, the use of class 1 TcDHODH
in similar ESR experiments resulted in no spectral changes,
thus suggesting that it is the N-terminal extension the domain
responsible for protein/membrane interaction.
The dynamics of the several spin probes can be discussed
in terms of R? and R// parameters. As observed previously in
other articles that made use of the NLSL program, we also
found that our simulations were insensitive to R//. Hence, this
value was kept fixed at R// ¼ 10 R? during all simulations
(27,46,47). In the absence of EcDHODH, R? values of the
chain labels followed an increasing gradient when one
goes down along the acyl chain of the spin probe molecule
(Table 1), which is compatible with the low-ordered and
highly flexible organization of molecules inside mixed ves-
icles of phospholipid/detergent. The headgroup label DPPTC
presents faster motion due to its exposition to the solvent,
resulting in a less immobilized regime of motion.
In the presence of EcDHODH, we observed a greater R?
value for the DPPTC probe and a decrease in R? values for
the bulk labels (component 1 in Table 1) positioned in the
hydrophobic part of the membrane as compared to the vesi-
cles without the protein (Table 1). The enzyme induces lower
fluidity of the carbon chains, while increasing the mobility of
the headgroup probe probably due to the breakage of hydro-
gen bonds that would otherwise be formed by the headgroup.
As for component 2 of the 5-PC ESR spectrum (Table 1), its
R? value (1.47 3 10
8 s1) increases significantly when
compared to the R? parameter (0.223 10
8 s1) obtained for
the same 5-PC localized in the vesicle bulk (component 1),
reaching rotational diffusion rates close to the ones observed
for 16-PC labels.
Our results allow us to conclude that the presence of
EcDHODH leads to a spacer effect between n¼ 5 and n¼ 10
carbon atoms of the DOPC vesicles. The determination of the
size of this region is not accurate because a system composed
of mixed vesicles does not present an ordering of the carbon
chains as high as phospholipid bilayers. Nonetheless, this is
strong evidence that a peripheral docking of the protein is
taking place. The high A0 and R? values (16.0 G and 1.473
108 s1, respectively) for component 2 of the 5- and 10-PC
probes indicate that a defect-like structure is formed by the
adhesion of the EcDHODHN-terminal domain to the vesicle.
The formation of defects in bilayers has been detected previ-
ously by ESR (48,49). Kleinschmidt et al. reported the ex-
istence of a sharp component in the ESR spectrum from a
spin-labeled stearic acid incorporated in DTPG bilayers after
addition of melittin (48). Ge et al. showed that binding of
ADP ribosylation factor 6 (ARF6), an activator of phos-
pholipase D, to phosphatidylinositol 4,5-bisphosphate (PIP2)-
containing vesicles creates defects in the bilayer structure at
the headgroup and/or near the n¼ 8–10 position of the carbon
acyl chain (26). Moreover, Ge et al. (49) concluded that the
sharp component can be significantly enhanced or reduced
through specific lipid/lipid or lipid/protein interactions.
The formation of such defect may play a fundamental role
in the catalytic cycle of the enzyme because the N-terminal
region is also responsible for regulating the access to the
protein active site. The crystal structure of HsDHODH in the
presence of several inhibitors showed that the N-terminal
FIGURE 6 Ribbon representation of EcDHODH structure emphasizing
the hydrophobicity pattern for N-terminal domain (comprising residues in
the two a-helices and one 310 helix) as determined by ProtScale software.
The dehydrogenase-active domain is shown in cyan. Hydrophobic and
hydrophilic residues in the N-terminal domain are colored in dark and light
gray, respectively.
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contains the site for quinone binding (10). The N-terminal
domain, along with the active site loop, acts as a cleft,
shielding the FMN cofactor and orotate from the solvent (11)
When bound to the membrane, the N-terminal induces the
appearance of the defect (spacer effect) so that quinones
dispersed in the membrane, which act as electron accep-
tors in the second half of the redox reaction catalyzed by
EcDHODH, can now bind to the protein. The appearance of
such defect is thus crucial for enzyme catalysis to take place.
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